-
Medicare Reimbursements Following Confirmatory MRI-Guided Biopsy vs. Systematic Biopsy Only in Low-Risk and Favorable Intermediate-Risk Prostate Cancer: A Real-World Cost Analysis Among Elderly Medicare Beneficiaries
Sep 9, 2025, 16:22 PM -
How Do Neurologists Perceive the Organization and Functioning of Care in Their Multiple Sclerosis Units?
Sep 9, 2025, 16:22 PM -
Clinical and Economic Burden Imposed by Transthyretin Amyloidosis Cardiomyopathy (ATTR-CM) in Belgium
Sep 9, 2025, 16:22 PM -
What Prompt Engineering Missed and How Context Engineering Fixes It
Sep 9, 2025, 16:22 PM -
Provisional Listing of Digital Healthcare Applications Digas Improves Patients' Access to Healthcare in Germany
Sep 9, 2025, 16:22 PM -
Budget Impact of an Ambulatory Minimally Invasive Surgical Treatment in an Italian Public Hospital
Sep 9, 2025, 16:22 PM -
APDS Treatment in Germany: Decision Criteria, Costs, and Contribution of Leniolisib to Outcomes
Sep 9, 2025, 16:22 PM -
Prognostic Factor Evaluation for Clinical Outcomes in HER2-Mutant NSCLC
Sep 9, 2025, 16:22 PM -
A New Regulatory-Grade Chronic Disease Cohort Simulator: Leveraging the Large, Deep, and Long Constances Cohort Linked and Matched to the SNDS in France
Sep 9, 2025, 16:22 PM -
Unraveling the Challenges of Multiplex Cell Culture Technology Using the HTA Core Model
Sep 9, 2025, 16:22 PM -
Epidemiology Treatment Patterns and Outcomes in Gestational Trophoblastic Neoplasia: A Systematic Literature Review and Gap Analysis
Sep 9, 2025, 16:22 PM -
Incorporating Equity-of-Access Into Health Economic Evaluations: Surgical Task-Shifting for C-Sections in Sierra Leone
Sep 9, 2025, 16:22 PM -
Clinical Outcomes of Early Diagnosis of Infections of Sterile Body Fluids: A Living Systematic Review and Meta Analysis
Sep 9, 2025, 16:22 PM -
Weighting the OrPhar-SEFH MCDA Framework for Its Use in Ultrarare Kidney Diseases
Sep 9, 2025, 16:22 PM -
Budget Impact Analysis of Obecabtagene Autoleucel for Adults With Relapsed/Refractory B-cell ALL From a US Payer Perspective
Sep 9, 2025, 16:22 PM -
Real-World Evidence Study on Healthcare Resource Utilization (HCRU) Among Cancer Patients in the Helsinki and Uusimaa (HUS) Region, Finland
Sep 9, 2025, 16:22 PM -
Comparative Health Economic Evaluation of Alzheimer’s Diagnostic Treatment Strategies in the Era of Amyloid-Targeting Therapies: A Conceptual Model Framework
Sep 9, 2025, 16:22 PM -
The Phantom Menace: How Consultations and Appeals During NICE HST Appraisals Contribute to Delays in Patient Access
Sep 9, 2025, 16:22 PM -
Real-World Healthcare Resource Utilization and Related Costs Associated With Schizophrenia in the Brazilian Private Market
Sep 9, 2025, 16:22 PM -
Use of Big Data to Assess Dyslipidemia Management in Greece: Real-World Insights From the National Healthcare Payer
Sep 9, 2025, 16:22 PM
